Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DM

PHASE3CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

January 31, 2012

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Continuous glucose monitor

Daily use of a continuous glucose monitor

DEVICE

Home blood glucose monitor

Home monitoring 3 or more times a day

Trial Locations (5)

32207

Nemours Children's Clinic, Jacksonville

52242

Children's Hospital of Iowa, Department of Pediatrics, Iowa City

63110

Washington University School of Medicine, St Louis

94305

Stanford University Medical Center, Stanford

06520

Yale University, School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Jaeb Center for Health Research

OTHER